首页 > 市场调查报告书 > 医疗设备

病患监测

市场调查报告书

商品编码

1542902

全球骨密度仪设备市场 - 2024-2031

Global Bone Densitometer Devices Market - 2024-2031

出版日期: 2024年08月26日 | 出版商:

DataM Intelligence | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场规模

全球骨密度仪市场在2023年达到3.1136亿美元，预计到2031年将达到4.5273亿美元，在2024-2031年预测期间复合年增长率为4.8%。

骨密度计是一种医学影像设备，用于测量骨密度，以确定患者是否患有骨质疏鬆症，骨质疏鬆症的症状是骨骼更脆弱，更容易骨折。密度计利用 X 光来估计一段骨头中填充了多少克钙和其他骨矿物质。

骨密度仪市场趋势

骨质疏鬆症盛行率不断上升

骨密度仪设备的全球市场成长预计将受到预测期内骨质疏鬆症盛行率不断上升的推动。据国际骨质疏鬆基金会称，预计到2050 年，男性髋部骨折的发生率将增加300% 以上，女性髋部骨折的发生率将增加240%。疾病的盛行率增加，凸显了进行骨骼检查的必要性。

根据 IOF（国际骨质疏鬆症基金会）的数据，全球每年有超过 890 万例骨折是由骨质疏鬆症引起的，每 3 秒就会发生一次骨质疏鬆性破裂。此外，美国国立卫生研究院估计，有超过 2 亿人患有骨质疏鬆症。此外，国际骨质疏鬆基金会的统计数据表明，50岁以上的女性中有三分之一和男性中有五分之一预计在一生中会遭遇骨质疏鬆性骨折。

此外，老年人口的成长和研究活动的增加是预测期内推动全球市场的其他因素。

骨密度仪成本高

然而，骨密度计的高成本预计将阻碍预测期内全球骨密度计市场的成长。例如，早期的 GE Prodigy 系列、GE DPX 系列和 Hologic Discovery 系列的价格约为 16,000 美元至 21,000 美元。后来的GE Prodigy系列、后来的Hologic Discovery系列和早期的Hologic Horizon系列售价为22,000 - 28,000美元，而最新的GE Prodigy系列、GE iDXA和Hologic Horizons A和W售价在30,000 - 45,000美元之间，从而减缓了全球骨密度仪市场的发展预测期内的增长。

骨密度仪市场细分

全球骨密度计设备市场根据技术、应用、最终用户和地区进行细分。

双能量 X 射线吸收测定法 (DEXA) 技术领域预计将主导市场

在预测期内，全球骨密度仪市场预计将由双能量X射线骨密度仪（DEXA）主导。 DEXA 因其许多优点而优于其他骨密度计设备技术。透过让骨骼发出两种不同能量水平的 X 射线，DEXA 可以测量骨骼中钙和矿物质的比例。其优点包括辐射剂量低、准确且简单。

此外，与电脑断层扫描和磁振造影相比，DXA 可以提供非常准确的脂肪量 (FM) 和瘦体重 (LM) 值读数。根据《Bone Journal》报导，DEXA 是估计骨矿物质密度 (BMD)、诊断骨质疏鬆症以及监测 BMD 随时间变化以确定骨折风险的黄金标准。超音波检查的使用频率低于 DEXA，因为没有使用超音波测量来诊断骨质疏鬆症或预测骨折风险的精确指南。因此，根据上述资料，预计DEXA将在整个预测期内继续主导全球骨密度计设备市场。

骨密度仪市场地域份额

北美可望主导全球市场

预计在整个预测期内，北美将占据全球骨密度计市场的最大份额。这是由于该地区停经后女性人口不断增加。例如，根据北美更年期协会的数据，每年有超过 200 万名美国女性进入更年期，预计到 2026 年，近四分之一的加拿大居民将是 50 岁以上的女性。 , Inc.、Tecnicare Healthcare Co、Hologic, Inc. 和GE Healthcare 等公司在骨密度仪市场上占有相当大的份额，确保了该地区的主导地位。

这些主要参与者透过产品发布、合作伙伴关係、市场审批、收购、合作等多样化的市场策略，占领了主要市场份额。深入推动了该地区在全球骨密度计市场的主导地位。例如，UnitedHealthcare 于 2022 年 9 月批准了骨量测量 (BMM) 的医疗保险承保，骨量测量是一种放射学、放射性同位素或其他程序。

COVID-19 影响分析

COVID-19 大流行对骨密度仪市场产生了重大影响，因为根据《欧洲医学和药理学科学评论》，继发性骨质疏鬆症可能是 COVID-19 的急性后后果。因此，需要在追踪时密切观察COVID-19住院后患者的骨骼健康状况，以利于骨质疏鬆併发症的预防和早期治疗。

此外，印第安纳大学研究人员表示，根据长期研究，即使是轻微的 COVID-19 感染也会导致骨密度快速且显着的下降。因此，监测 COVID-19 感染患者骨密度的需求增加，增加了对骨密度计设备的需求，并对全球骨密度计设备市场的成长产生正面影响。

主要进展

2021 年5 月，在佛罗里达州骨科学会年度科学会议上，Echolight 推出了射频回波多光谱测量(REMS)，这是第一个以便携式骨密度计形式提供的无辐射技术，可以在更高的温度下安全地扫描基本的骨骼健康指标。

2021 年 5 月，临床诊断领导者 Beckman Coulter 推出了 DxA 5000 Fit，这是一种工作流程自动化解决方案，专为适合每天执行少于 5,000 项测试的中型实验室而开发。

骨密度仪市场关键参与者

该市场的主要全球参与者包括 GE Healthcare、BeamMed、Diagnostic Medical System、Eco light Healthcare、Hologic Inc.、Medonica、Osteosys、Swissray、OSI Systems, Inc. 和 Tecnicare Healthcare Co。

为什么购买报告？

根据技术、应用、最终用户和地区可视化全球骨密度计设备市场细分，并了解关键商业资产和参与者。

透过分析趋势和共同开发来识别商业机会。

Excel资料表包含所有细分市场层级的骨密度计设备的大量资料点。

PDF 报告由详尽的质性访谈和深入研究后的综合分析组成。

产品映射以 Excel 形式提供，包含所有主要参与者的关键产品。

全球骨密度仪设备市场报告将提供约 61 个表格、58 个图表和 182 页。

2024 年目标受众

製造商/买家

产业投资者/投资银行家

研究专业人员

新兴公司

A bone densitometer is a medical imaging device employed to measure bone density to determine if the patient has osteoporosis, a disorder indicated by more fragile bones that are more likely to break. The densitometer utilizes X-rays to estimate how many grams of calcium and other bone minerals are filled into a segment of bone.

Bone Densitometer Market Trends

Growing Prevalence of Osteoporosis

The global market growth for Bone Densitometer Devices is expected to be driven by the growing prevalence of osteoporosis during the forecast period. According to the International Osteoporosis Foundation, there is an anticipated over 300% gain in hip fractures among males and a 240% boost among females by 2050. This highlights the necessity for bone examination, pushed by the increased preponderance of osteoporosis and corresponding disorders like osteopenia, osteomalacia, and osteoporotic fractures.

Globally, over 8.9 million fractures annually are rendered by osteoporosis, resulting in an osteoporotic rupture every 3 seconds, according to the IOF (International Osteoporosis Foundation). Moreover, the NIH estimated that over 200 million individuals suffer from osteoporosis. Moreover, statistics from the International Osteoporosis Foundation indicate that 1 in 3 females over the age of 50 years and 1 in 5 males are expected to encounter osteoporotic fractures in their lifetime.

Additionally, the growing geriatric population and increased research activities are among the additional factors boosting the global market during the forecast period.

High Cost of Bone Densitometer

However, the high cost of the bone densitometer is expected to hamper the global bone densitometer market growth during the forecast period. For instance, the early GE Prodigy Series, GE DPX series, and Hologic Discovery series cost roughly $16,000 to $21,000. The later GE Prodigy series, later Hologic Discovery series, and the early Hologic Horizon series cost $22,000 - $28,000 while the latest GE Prodigy series, GE iDXA, and Hologic Horizons A and W cost between $30,000 - $45,000 thus, slowing the global bone densitometer market growth during the forecast period.

Bone Densitometer Market Segmentation

The global bone densitometer devices market is segmented based on technology, application, end user and region.

Dual-Energy X-ray Absorptiometry (DEXA) Technology Segment is Expected to Dominate Market

During the forecast period, the global bone densitometer market is expected to be dominated by dual-energy X-ray absorptiometry (DEXA). DEXA is preferred over other bone densitometer device techniques because of its many advantages. By passing X-rays with two different energy levels from the bone, DEXA measures the proportion of calcium and minerals in the bones. Its advantages include low radiation dose, accuracy, and simplicity.

In addition, compared with computed tomography and magnetic resonance imaging, DXA provides very accurate readings of fat mass (FM) and lean mass (LM) values. According to Bone Journal, DEXA is the gold standard for estimating bone mineral density (BMD), diagnosing osteoporosis, and monitoring changes in BMD over time to determine fracture risk. Ultrasound is less frequently used than DEXA because there are no precise guidelines for using ultrasound measurement to diagnose osteoporosis or predict fracture risk. Therefore, based on the above data, it is expected that DEXA will continue to dominate the global bone densitometer device market throughout the forecast period.

Bone Densitometer Market Geographical Share

North America is Expected to Dominate the Global Market

North America is expected to hold the largest share of the global bone densitometer market throughout the forecast period. This is owing to the growing post-menopausal female population in the region. For instance, according to the North American Menopause Society, over 2 million US females attain menopause annually, and it is estimated that by 2026, nearly one-quarter of the Canadian residents will be females over 50. Moreover, the presence of major market players such as OSI Systems, Inc., Tecnicare Healthcare Co., Hologic, Inc., and GE Healthcare, who hold a substantial share of the bone densitometer market, ensures the dominance of this region.

These key players have captured a major share of the market via diverse market strategies such as product launches, partnerships, market approvals, acquisitions, collaborations, etc. Additionally, the new policy guidelines of different healthcare and insurance companies in the United States for the reimbursement of bone density studies are contributing to the dominance of this region over the global bone densitometer market. For example, UnitedHealthcare, in September 2022, approved Medicare coverage for Bone Mass Measurement (BMM), which is a radiologic, radioisotope, or other procedure.

COVID-19 Impact Analysis

The COVID-19 pandemic has significantly influenced the bone densitometer market since, according to the European Review for Medical and Pharmacological Sciences, there is the possibility of Secondary osteoporosis as a post-acute consequence of COVID-19. Thus, the bone health situation of patients outliving COVID-19 hospitalization needs to be observed closely at follow-up visits, facilitating the prevention and early treatment of osteoporosis complications.

Furthermore, according to Indiana University researchers, even a mild infection of COVID-19 can cause rapid and significant bone density loss, according to long-term research. Therefore, increasing the need for monitoring the bone density of the patients who suffered COVID-19 infection, increasing the demand for bone densitometer devices and positively impacting the global bone densitometer device market growth.

Key Developments

In May 2021, At the Florida Orthopedic Society Annual Scientific Meeting, Echolight introduced Radiofrequency Echographic Multi Spectrometry (REMS), the first radiation-free technology provided in the shape of a portable bone densitometer that can safely scan essential bone health indicators at a more elevated frequency than different testing methods.

In May 2021, Beckman Coulter, a clinical diagnostics leader, launched the DxA 5000 Fit, a workflow-automation solution developed to fit into medium-sized labs that execute less than 5,000 tests per day.

Bone Densitometer Market Key Players

The major global players in the market include GE Healthcare, BeamMed, Diagnostic Medical System, Eco light Healthcare, Hologic Inc., Medonica, Osteosys, Swissray, OSI Systems, Inc. and Tecnicare Healthcare Co.

Why Purchase the Report?

To visualize the global bone densitometer devices market segmentation based on technology, application, end user and region as well as understand key commercial assets and players.

Identify commercial opportunities by analyzing trends and co-development.

Excel data sheet with numerous data points of bone densitometer devices market-level with all segments.

PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.

Product mapping available as excel consisting of key product of all the major players.

The global bone densitometer devices market report would provide approximately 61 tables, 58 figures and 182 pages.

Target Audience 2024

Manufacturers/ Buyers

Industry Investors/Investment Bankers

Research Professionals

Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Technology
3.2. Snippet by Application
3.3. Snippet by End User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Growing Prevalence of Osteoporosis
- 4.1.2. Restraints
  - 4.1.2.1. High Cost of Bone Densitometer
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Pricing Analysis
5.3. Regulatory Analysis
5.4. Patent Analysis
5.5. Technology and Trend Analysis
5.6. Unmet Need
5.7. SWOT Analysis
5.8. DMI Opinion

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID
- 6.1.2. Scenario During COVID
- 6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Technology

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 7.1.2. Market Attractiveness Index, By Technology
7.2. Dual Energy X-Ray Absorptiometry (DEXA)*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Quantitative Computed Tomography
7.4. Quantitative Ultrasound
7.5. Single Energy X-Ray Absorptiometry
7.6. Others

8. By Application

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.1.2. Market Attractiveness Index, By Application
8.2. Peripheral Bone Densitometry*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Axial Bone Densitometry

9. By End User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.1.2. Market Attractiveness Index, By End User
9.2. Hospitals*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Specialty Clinics
9.4. Others

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.6.1. U.S.
  - 10.2.6.2. Canada
  - 10.2.6.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.6.1. Germany
  - 10.3.6.2. UK
  - 10.3.6.3. France
  - 10.3.6.4. Italy
  - 10.3.6.5. Spain
  - 10.3.6.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.6.1. Brazil
  - 10.4.6.2. Argentina
  - 10.4.6.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.6.1. China
  - 10.5.6.2. India
  - 10.5.6.3. Japan
  - 10.5.6.4. Australia
  - 10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. GE Healthcare*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. BeamMed
12.3. Diagnostic Medical System, Inc.
12.4. ECO LIGHT HEALTHCARE
12.5. Hologic Inc.
12.6. Medonica
12.7. Osteosys
12.8. Swissray
12.9. OSI Systems, Inc.
12.10. Tecnicare Healthcare Co.

LIST NOT EXHAUSTIVE